Dapagliflozin for Cardio-renal Protection After ICU Discharge

NCT07025629 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

600

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure and Chronic Kidney Disease Post-ICU

Interventions

DRUG: Dapagliflozin 10 MG Oral Tablet [Farxiga]
DRUG: One tablet of placebo of dapagliflozin 10 mg

Sponsor

Assistance Publique - Hôpitaux de Paris